PetVivo (NASDAQ:PETV) and Minerva Surgical (NASDAQ:UTRS) Head to Head Analysis

Institutional and Insider Ownership

24.5% of PetVivo shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares PetVivo and Minerva Surgical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05 million	20.65	-$10.95 million	($0.42)	-1.87
Minerva Surgical	$51.69 million	0.00	-$34.11 million	N/A	N/A

PetVivo has higher earnings, but lower revenue than Minerva Surgical.

Profitability

This table compares PetVivo and Minerva Surgical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Minerva Surgical	N/A	N/A	N/A

Volatility & Risk

PetVivo has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 3.53, meaning that its stock price is 253% more volatile than the S&P 500.

Summary

Minerva Surgical beats PetVivo on 5 of the 8 factors compared between the two stocks.

About PetVivo

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

About Minerva Surgical

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.